MedTrace Logo

Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke

NCT02074111 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2017-04-26

No results posted yet for this study

Summary

The aim of this study is to investigate the proportion of patients with moyamoya disease among the patients who were diagnosed as having intracranial atherosclerotic stroke. To do this, biomarkers (gene and imaging) for moyamoya disease are tested and follow up angiography are performed during follow up (in selected patients).

Conditions

  • Moyamoya Disease
  • Intracranial Atherosclerotic Stroke
  • Intracranial Steno-occlusive Disease

Sponsors & Collaborators

  • Samsung Medical Center

    lead OTHER

Principal Investigators

  • Oh Young Bang, MD PhD · Associate Professor

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2019-12-31
Completion
2019-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02074111 on ClinicalTrials.gov